Cancer cell membrane-coated siRNA-Decorated Au/MnO<sub>2</sub> nanosensitizers for synergistically enhanced radio-immunotherapy of breast cancer.
Ontology highlight
ABSTRACT: Radiotherapy plays a critical role in the clinical treatment of breast cancer. However, the efficacy of traditional X-ray radiotherapy is greatly limited by its low tumor specificity and treatment tolerance mediated by the tumor microenvironment. Herein, we proposed a novel nano-radiotherapy sensitization strategy to design and construct a cancer cell membrane-coated siRNA-decorated Au/MnO2 nanosensitizer (R&F@Au/MnO2-CM) to synergistically enhance radio-immunotherapy for breast cancer. In the integrated nanosensitizer, the cancer cell membrane (CM) derived from 4T1 breast cancer cells is utilized for targeted functionality, while Au/MnO2 is designed to improve X-ray absorption and alleviate tumor hypoxia. Additionally, PD-L1 siRNA (R) is used to downregula
SUBMITTER: Wang D
PROVIDER: S-EPMC11471673 | biostudies-literature | 2024 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA